Company
ADIAL PHARMACEUTICALS, INC. (ADIL)
Standardized SEC financial data for ADIAL PHARMACEUTICALS, INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001513525 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-151.2%
Free cash flow
-$6.6M
Current ratio
4.42×
EPS (diluted)
$-11.93
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $8.4M | $2.0M | $1.3M | $3.2M | — | $2.6M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.4M | $6.1M | $4.0M | $2.8M | $3.8M | $5.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$7.6M | -$11.9M | -$11.2M | -$6.8M | -$6.9M | -$6.5M |
| Capital expenditures |
Get ADIL data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ADIL/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ADIL/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"